Huahai Pharma to hold 2024 results briefing

Zhejiang Huahai Pharmaceutical Co., Ltd. (SSE:600521) announced it will hold a performance briefing on June 3, 2025, to discuss the company’s 2024 annual results and its performance in the first quarter of 2025. The briefing will take place from 15:00 to 16:00 (GMT+8) and will be conducted via live video broadcast and online interaction through the Shanghai Stock Exchange Roadshow Center. Investors can submit questions in advance via the SSE Roadshow Center website or by emailing 600521@huahaipharm.com between May 26 and May 30. Company executives including Chairman Chen Baohua, Vice President Zhu Yonghua, and CFO Zhang Mei will be present to address investor concerns. Recordings and materials from the briefing will be available on the SSE Roadshow Center website.